SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 137 filers reported holding SUTRO BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,684 | -11.7% | 773,867 | +18.2% | 0.01% | -8.3% |
| Q2 2023 | $3,041 | -4.2% | 654,468 | -4.8% | 0.01% | -14.3% |
| Q1 2023 | $3,173 | -30.1% | 687,235 | +22.3% | 0.01% | -36.4% |
| Q4 2022 | $4,538 | -99.9% | 561,828 | -11.1% | 0.02% | +15.8% |
| Q3 2022 | $3,504,000 | +1.7% | 631,800 | -4.5% | 0.02% | +5.6% |
| Q2 2022 | $3,447,000 | +76.2% | 661,615 | +177.8% | 0.02% | +125.0% |
| Q1 2022 | $1,956,000 | -8.5% | 238,157 | +65.7% | 0.01% | 0.0% |
| Q4 2021 | $2,137,000 | -37.9% | 143,718 | -21.2% | 0.01% | -38.5% |
| Q3 2021 | $3,442,000 | -16.8% | 182,288 | -18.1% | 0.01% | -18.8% |
| Q2 2021 | $4,135,000 | -23.5% | 222,469 | -6.3% | 0.02% | -23.8% |
| Q1 2021 | $5,404,000 | +107.1% | 237,393 | +97.6% | 0.02% | +110.0% |
| Q4 2020 | $2,609,000 | +104.6% | 120,163 | -5.3% | 0.01% | +100.0% |
| Q3 2020 | $1,275,000 | +75.6% | 126,910 | +35.6% | 0.01% | +66.7% |
| Q2 2020 | $726,000 | -20.0% | 93,566 | +5.2% | 0.00% | -40.0% |
| Q1 2020 | $908,000 | +81.2% | 88,946 | +95.7% | 0.01% | +150.0% |
| Q4 2019 | $501,000 | +79.6% | 45,447 | +48.0% | 0.00% | +100.0% |
| Q3 2019 | $279,000 | +170.9% | 30,711 | +239.0% | 0.00% | – |
| Q2 2019 | $103,000 | +1371.4% | 9,058 | +1365.7% | 0.00% | – |
| Q1 2019 | $7,000 | – | 618 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
| Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
| Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
| Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
| BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
| DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
| SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
| Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
| Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |